The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
Mutual Fund to ETF Converter Tool
We’re sorry, there are no active ETFs associated with this index.
Sort By:
ETF Database staff has allocated each ETF in the ETF database, as well as each index, to a single ‘best-fit’ ETF Database Category. Other ETFs in the Health & Biotech Equities ETF Database Category are presented in the following table.
* Assets in thousands of U.S. Dollars.
Historical return data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Fund flow information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Expense information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Dividend information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Holdings data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Tax Rate data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Technical information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to analysis of other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to a proprietary ETF Database rating for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
| Symbol | ETF Name | Asset Class | Total Assets* | YTD | Avg Volume | Previous Closing Price | 1-Day Change | Overall Rating | 1 Week | 1 Month | 1 Year | 3 Year | 5 Year | YTD FF | 1 Week FF | 4 Week FF | 1 Year FF | 3 Year FF | 5 Year FF | ETF Database | Inception | ER | Commission Free | Annual Dividend Rate | Dividend Date | Dividend | Annual Dividend Yield % | P/E Ratio | Beta | # of Holdings | % In Top 10 | Complete | ST Cap Gain Rate | LT Cap Gain Rate | Tax Form | Lower Bollinger | Upper Bollinger | Support 1 | Resistance 1 | RSI | Advanced | Fact Sheet | ETF Holdings | Chart | ETF Home Page | Head-To-Head | Liquidity Rating | Expenses Rating | Returns Rating | Volatility Rating | Dividend Rating | Concentration Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR Fund | Equity | $38,853,200 | 6.9% | 8,507,535.0 | $147.01 | 0.06% | 2.2% | 0.4% | 2.3% | 4.0% | 14.1% | Health & Biotech Equities | 1998-12-16 | 0.09% | N/A | $2.30 | 2024-12-23 | $0.62 | 1.56% | 16.7 | 0.70 | 62 | 56.7% | View | 40% | 20% | 1099 | $144.22 | $150.43 | $146.47 | $147.59 | 52.26 | View | View | View | View | View | View | A | A | |||||||||||
| VHT | Vanguard Health Care ETF | Equity | $16,687,800 | 5.5% | 276,822.0 | $267.62 | 0.01% | 2.3% | -0.7% | 1.6% | 3.1% | 13.4% | Health & Biotech Equities | 2004-01-26 | 0.10% | Vanguard | $3.87 | 2024-12-18 | $0.92 | 1.45% | 22.0 | 0.73 | 409 | 48.4% | View | 40% | 20% | 1099 | $262.80 | $274.26 | $266.59 | $268.82 | 50.23 | View | View | View | View | View | View | A | A | |||||||||||
| IBB | iShares Biotechnology ETF | Equity | $6,060,570 | 0.5% | 1,315,990.0 | $132.74 | -1.36% | -0.2% | -4.2% | -2.4% | 0.8% | 5.9% | Health & Biotech Equities | 2001-02-05 | 0.45% | N/A | $0.38 | 2025-03-18 | $0.12 | 0.29% | 15.7 | 0.84 | 259 | 51.8% | View | 40% | 20% | 1099 | $132.19 | $139.14 | $131.92 | $134.17 | 43.48 | View | View | View | View | View | View | A | B | |||||||||||
| XBI | SPDR S&P Biotech ETF | Equity | $5,658,420 | -3.8% | 8,723,950.0 | $86.59 | -0.99% | 0.7% | -6.4% | -8.9% | -2.0% | 4.4% | Health & Biotech Equities | 2006-01-31 | 0.35% | N/A | $0.13 | 2024-12-23 | $0.00 | 0.15% | 17.9 | 0.97 | 140 | 26.7% | View | 40% | 20% | 1099 | $84.51 | $90.65 | $86.04 | $87.63 | 44.26 | View | View | View | View | View | View | A+ | A | |||||||||||
| IHI | iShares U.S. Medical Devices ETF | Equity | $4,721,760 | 2.7% | 869,250.0 | $59.92 | -0.12% | 2.3% | -7.5% | 5.4% | 0.2% | 12.3% | Health & Biotech Equities | 2006-05-01 | 0.40% | N/A | $0.27 | 2025-03-18 | $0.03 | 0.45% | 34.2 | 0.85 | 49 | 76.1% | View | 40% | 20% | 1099 | $57.68 | $65.85 | $59.66 | $60.28 | 40.46 | View | View | View | View | View | View | A | A- | |||||||||||
| IXJ | iShares Global Healthcare ETF | Equity | $4,022,160 | 7.4% | 192,380.0 | $92.34 | 0.04% | 2.2% | 1.0% | 1.8% | 3.3% | 12.0% | Health & Biotech Equities | 2001-11-13 | 0.41% | N/A | $1.29 | 2024-12-17 | $0.62 | 1.40% | 21.8 | 0.67 | 113 | 43.8% | View | 40% | 20% | 1099 | $90.53 | $94.34 | $92.07 | $92.59 | 53.24 | View | View | View | View | View | View | A | B+ | |||||||||||
| IYH | iShares U.S. Healthcare ETF | Equity | $3,229,350 | 5.4% | 323,612.0 | $61.23 | 0.03% | 2.2% | -0.2% | 1.6% | 3.3% | 13.4% | Health & Biotech Equities | 2000-06-12 | 0.39% | N/A | $0.72 | 2025-03-18 | $0.16 | 1.18% | 21.7 | 0.71 | 107 | 55.5% | View | 40% | 20% | 1099 | $60.11 | $62.93 | $61.02 | $61.49 | 50.08 | View | View | View | View | View | View | B+ | B+ | |||||||||||
| FHLC | Fidelity MSCI Health Care Index ETF | Equity | $2,746,200 | 5.4% | 159,097.0 | $68.87 | -0.16% | 2.2% | -0.9% | 1.3% | 3.1% | 13.3% | Health & Biotech Equities | 2013-10-21 | 0.08% | Fidelity | $0.99 | 2024-12-20 | $0.26 | 1.43% | 21.8 | 0.72 | 344 | 49.9% | View | 40% | 20% | 1099 | $67.75 | $70.69 | $68.65 | $69.22 | 49.62 | View | View | View | View | View | View | A | A+ | |||||||||||
| FBT | First Trust NYSE Arca Biotechnology Index Fund | Equity | $1,116,920 | 0.5% | 26,128.0 | $167.02 | -1.47% | 0.1% | -6.1% | 10.0% | 4.1% | 7.4% | Health & Biotech Equities | 2006-06-19 | 0.56% | N/A | $1.17 | 2024-12-13 | $1.17 | 0.69% | 17.6 | 0.79 | 31 | 41.8% | View | 40% | 20% | 1099 | $165.43 | $179.18 | $166.31 | $168.44 | 41.33 | View | View | View | View | View | View | B+ | B- | |||||||||||
| ARKG | ARK Genomic Revolution ETF | Equity | $1,072,160 | -2.9% | 3,461,483.0 | $22.86 | -1.04% | 3.8% | -23.3% | -20.8% | -20.9% | -3.0% | Health & Biotech Equities | 2014-10-31 | 0.75% | N/A | $0.00 | 2021-12-29 | $0.38 | 0.00% | N/A | 1.50 | 34 | 62.1% | View | 40% | 20% | 1099 | $20.88 | $26.72 | N/A | N/A | 43.20 | View | View | View | View | View | View | A | C+ | |||||||||||
| Click Here to Join to ETF Database Pro for 14 Days Free, Export This Data & So Much More | ||||||||||||||||||||||||||||||||||||||||||||||||||||
A long-running debate in asset allocation circles is how much of a portfolio an investor should...
In a digital age where information moves in milliseconds and millions of participants can transact...